Africa: False Guarantees – Russian Navy Trafficking in Africa

Africa Dangers Lacking AI Revolution As UN Urges Borrowing to Shut Infrastructure Hole

African nations could miss out on the transformative advantages of the worldwide synthetic intelligence (AI) revolution until pressing investments are made in essential infrastructure, the United Nations Financial Fee for Africa (ECA) has warned. In a report introduced at a gathering of African ministers of finance in Morocco, the ECA stated the continent’s greater than…

Read More
Africa: False Guarantees – Russian Navy Trafficking in Africa

Africa: Mólly Ephraim Academy – 10years of Empowering Africa’s Subsequent Technology of Entrepreneurs

Mólly Ephraim Academy, an African entrepreneurship improvement academy based by Nigerian entrepreneur Mólly Ephraim is driving reasonably priced entrepreneurship schooling throughout Africa, and offering funding alternatives for early-stage entrepreneurs. Since launching out in March 2016, along with her first program –PROJECT 1000, the academy has delivered applications and initiatives in keeping with the United Nations…

Read More
Africa: False Guarantees – Russian Navy Trafficking in Africa

Africa: AUC Chairperson Throughout This Morning’s Opening Session of the Ministerial Phase of the Fifty-Eighth Session of the Financial Fee for Africa Convention of African Ministers of Finance, Planning and Financial Growth in Tangier, Morocco

Throughout this morning’s opening session of the ministerial section of the Fifty-eighth session of the Financial Fee for Africa Convention of African Ministers of Finance, Planning and Financial Growth in Tangier, Morocco, H.E. Mahmoud Ali Youssouf, Chairperson of the AU Fee, joined H.E. Nadia Fettah, Minister of Economic system & Finance of Morocco, H.E. @NOIweala,…

Read More
Africa: Gilead Underneath Fireplace for Not Promoting HIV Drug Lenacapavir to MSF

Africa: Gilead Underneath Fireplace for Not Promoting HIV Drug Lenacapavir to MSF

Pharmaceutical firm Gilead Sciences has come below mounting stress after refusing to promote its breakthrough HIV prevention drug, lenacapavir, on to Médecins Sans Frontières (MSF), regardless of repeated requests. In an open letter, the group renewed its repeated requests to California-based Gilead to promote the drug, saying the corporate is obstructing lenacapavir’s rollout. MSF stated it had sought to…

Read More